Cargando…

Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation

BACKGROUND: To evaluate the prognostic value of metabolic parameters of pre-treatment and interim 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for overall survival (OS) of esophageal cancer(EC) patients undergoing (chemo-) radiotherapy. METHODS: A retrospective analysis of 134 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yimin, Zschaeck, Sebastian, Lin, Qin, Chen, Sijia, Chen, Lili, Wu, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381652/ https://www.ncbi.nlm.nih.gov/pubmed/30782182 http://dx.doi.org/10.1186/s13014-019-1236-x

Ejemplares similares

Sequential delayed [18 F]FDG PET/CT examinations in the pharynx
por: Pietrzak, Agata Karolina, et al.
Publicado: (2020)

[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy
por: Herrera, Fernanda G., et al.
Publicado: (2016)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

(18)F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
por: Mantziari, Styliani, et al.
Publicado: (2020)

Identification of (18)F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer
por: Galvez, Thierry, et al.
Publicado: (2023)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

A (18)FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer
por: Song, Jinling, et al.
Publicado: (2019)

Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates
por: Quinn, Brian, et al.
Publicado: (2016)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

The Prognostic Value of Sequential (18) F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy
por: Ha, Le Ngoc, et al.
Publicado: (2023)

The Use of (18)F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma
por: Hlongwa, Khanyisile N., et al.
Publicado: (2022)

SPDL1 Overexpression Is Associated With the 18F-FDG PET/CT Metabolic Parameters, Prognosis, and Progression of Esophageal Cancer
por: Liu, Hua-Song, et al.
Publicado: (2022)

Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
por: Connor, Steve, et al.
Publicado: (2021)

P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOSTIC FOR OVERALL AND PROGRESSION-FREE SURVIVAL IN PERIPHERAL T-CELL LYMPHOMA: RESULTS OF THE UK NCRI PHASE 2 RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY
por: Gleeson, M., et al.
Publicado: (2022)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

(18)F-FDG PET/CT in Patients with Parenchymal Changes Attributed to Radiation Pneumonitis
por: Demirev, Anastas Krassenov, et al.
Publicado: (2018)

(18)F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
por: Mouminah, Alaa, et al.
Publicado: (2020)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
por: Groshar, David, et al.
Publicado: (2017)

(18) F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose
por: Massaccesi, Mariangela, et al.
Publicado: (2012)

Prognostic value of post-induction chemotherapy (18)F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation
por: Ganem, Julien, et al.
Publicado: (2019)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
por: Bayar, Melikşah, et al.
Publicado: (2021)

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation
por: Li, Yimin, et al.
Publicado: (2020)

What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
por: Kunikowska, Jolanta, et al.
Publicado: (2014)

Clinical correlation of metabolic parameters on (18)F-FDG PET/CT in idiopathic frozen shoulder
por: Won, Kyoung Sook, et al.
Publicado: (2017)

Prognostic Significance of Metabolic Parameters by (18)F-FDG PET/CT in Thymic Epithelial Tumors
por: Lee, Joohee, et al.
Publicado: (2021)

Reducing Radiation Exposure to Paediatric Patients Undergoing [18F]FDG-PET/CT Imaging
por: Kertész, Hunor, et al.
Publicado: (2021)

[F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
por: Walter, Franziska, et al.
Publicado: (2020)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bbfl2i3u37qrb2to51kd5rssqa